M. Jinek, A programmable dual-RNA-guided DNA endonuclease in adaptive 479 bacterial immunity, Science, vol.337, pp.816-821, 2012.

L. Cong, Multiplex genome engineering using CRISPR/Cas systems, Science, vol.339, pp.819-823, 2013.

P. Mali, RNA-guided human genome engineering via Cas9, Science, vol.339, pp.823-826

C. Harrison, EPO revokes Broad's CRISPR patent, Nat. Biotechnol, vol.36, p.209, 2018.

D. Lim, Disruption and development: the evolving CRISPR patent and technology 486 landscape, Pharm. Pat. Anal, 2018.

K. J. Egelie, G. D. Graff, S. P. Strand, and B. Johansen, The emerging patent landscape of 488 CRISPR-Cas gene editing technology, Nat. Biotechnol, vol.34, pp.1025-1031, 2016.

E. J. Kim, K. H. Kang, and J. H. Ju, CRISPR-Cas9: a promising tool for gene editing on 490 induced pluripotent stem cells, Korean J. Intern. Med, vol.32, pp.42-61, 2017.

M. V. Maus and B. L. Levine, Chimeric antigen receptor T-Cell therapy for the 492 community oncologist, Oncologist, vol.21, pp.608-617, 2016.

W. Feng, The potential of the combination of CRISPR/Cas9 and pluripotent stem 494 cells to provide human organs from chimaeric pigs, Int. J. Mol. Sci, vol.16, p.495, 2015.

R. Ferreira, F. David, and J. Nielsen, Advancing biotechnology with CRISPR/Cas9: recent 497 applications and patent landscape, J. Ind. Microbiol. Biotechnol, vol.45, p.498, 2018.

A. E. Ricroch, K. Ammann, and M. Kuntz, Editing EU legislation to fit plant genome 500 editing: The use of genome editing technologies in plant breeding requires a 501 novel regulatory approach for new plant varieties that involves farmers, EMBO, vol.502, pp.1365-1369, 2016.

S. A. Bhat, Advances in genome editing for improved animal breeding: A review

, Vet. World, vol.10, pp.1361-1366, 2017.

A. Rodriguez-navarro and F. Narin, European Paradox or Delusion-Are European 506 Science and Economy Outdated?, Science and Public Policy, vol.45, pp.14-23, 2018.

J. S. Sherkow and . Crispr, Patents, and the Public Health, Yale J. Biol. Med, vol.90, pp.667-672, 2017.

J. S. Sherkow, Patent protection for CRISPR: an ELSI review, J. Law Biosci, vol.4, p.510, 2017.

J. S. Sherkow, F. Benahmed-miniuk, M. Kresz, J. K. Kanaujiya, and C. D. Southgate, 512 Inventive steps: the CRISPR patent dispute and scientific progress: The recent 513 patent decisions about CRISPR tell us a lot about how advances in biology are 514 actually made-and how they are not, EMBO Rep, vol.18, pp.1047-1051, 2017.

M. Kuntz and A. Berezow, Timidity and a hostility to competition have left Europe a 516 scientific wasteland. The Telegraph, 2017.

K. Brinegar, The commercialization of genome-editing technologies, Crit. Rev

. Biotechnol, , pp.1-12, 2017.

G. De-rassenfosse and E. Raiteri, Technology protectionism and the patent system: strategic 520 technologies in China, 2016.